OYOmer Yilmaz

Omer Yilmaz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Omer Yilmaz has a total of 68 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Radiodensity as a predictor: can penile and splenic Hounsfield units forecast clinical response to daily tadalafil?

    by Huseyin Hayit, Cumhur Yesildal, Omer Yilmaz, Yahya Barac, Kerem Bursali, Anil Yilmaz

    Background: Objective imaging biomarkers reflecting penile microvascular perfusion in erectile dysfunction are limited. Hounsfield unit measurements obtained from non-contrast computed tomography may offer a non-invasive approach to assess tissue perfusion. This retrospective cohort study evaluated the associations between penile and splenic tissue density values and erectile function scores, and explored their relationship with response to daily tadalafil therapy. Results: A total of 194 men with erectile dysfunction who underwent non-contrast lower abdominal computed tomography were included. Tissue density values were measured in proximal, midshaft, and distal penile segments as well as in splenic parenchyma. Daily tadalafil 5 mg was associated with statistically significant improvements across erectile function domains (mean change in erectile function score: +7.9 points; p < 0.0001). Baseline penile tissue density values demonstrated positive correlations with splenic tissue density, suggesting a potential association related to perfusion characteristics. Although responders exhibited lower baseline tissue density values in selected penile segments compared with non-responders, these parameters did not independently predict treatment response in multivariable analysis. Conclusions: Computed tomography–derived tissue density measurements of penile and splenic tissues may offer complementary, objective information related to tissue perfusion in men with erectile dysfunction. While these findings support the exploratory use of imaging-based density analysis in understanding vascular and metabolic influences on erectile function, prospective multicentre studies with standardized protocols are required to validate their clinical utility.

  • Open Access

    Comparative analysis of human telomerase reverse transcriptase mutation in transitional epithelial cell bladder cancer in high and low grade tumors

    by Mustafa Kaplan, Ece Seçgin Demir, İsMail Yılmaz, Ömer Yılmaz, Gizem Issın, Neslihan Kaya Terzi, Kerem Öz, Eriş Özkan, Başak Çakır Güney, İrFan Küçük, et al.

    Aims: We aimed to evaluate the presence of TERT promoter region mutations in transitional epithelial cell bladder cancer by analyzing the h-TERT mutation in high and low-grade tumors and to compare it with the clinicopathological data of the patients. Methods: A total of 90 patients diagnosed with bladder cancer, 60 with low-grade tumors and 30 with high-grade tumors were included in this study. To detect mutations in the TERT gene in the DNA samples obtained, the most frequently mutated region of the gene was amplified by PCR using forward and reverse primers and mutation analysis was performed by sequence analysis. Results: TERT promoter mutation was positive in 38 and negative in 22 out of 60 patients in the low grade group, and positive in 26 and negative in 4 out of 30 patients in the high grade group. Patients with high-grade tumors were 1.940 times more likely to be TERT promoter mutation positive than low-grade patients (p=0.027) Conclusion: When interpreted together with other studies that have obtained significant results that TERT mutation analysis can be used in diagnosis, tumor grading and follow-up, it is thought that it can be used in the grading and follow-up algorithm.

  • Open Access

    Biopsy with Ureterorenoscopy Before Radical Nephroureterectomy is Associated with Increased Intravesical Recurrence in Urothelial Cancer Located in the Kidney

    by Semih Turk, Asif Yildirim, Muhammet Abdurrahim Imamoglu, Gokhan Atis, Omer Yilmaz, Huseyin Cihan Demirel, Resul Sobay, Alper Otunctemur, Metin Ishak Ozturk, Selcuk Sahin, et al.

    Objective: Diagnostic ureterorenoscopy is used to identify upper tract urothelial cancer before radical nephroureterectomy, especially for uncertain lesions in imaging modalities or urine cytology. However, diagnostic ureterorenoscopy can potentially cause intravesical tumor spillage and can increase intravesical recurrence rates. We aimed to investigate the impact of diagnostic ureterorenoscopy before radical nephroureterectomy, with and without biopsy, on intravesical recurrence rates of patients with upper tract urothelial cancer. Material and methods: Patients with localized upper tract urothelial cancer from 8 different tertiary referral centers, who underwent radical nephroureterectomy between 2001 and 2020, were included. Three groups were made: no URS (group 1); diagnostic ureterorenoscopy without biopsy (group 2); and diagnostic ureterorenoscopy with biopsy (group 3). Intravesical recurrence rates and survival outcomes were compared. Univariate and multivariate Cox regression analyses were performed to determine the factors that were associated with intravesical recurrence-free survival. Results: Twenty-two (20.8%), 10 (24.4%), and 23 (39%) patients experienced intravesical recurrence in groups 1, 2, and 3, respectively (P=.037) among 206 patients. The 2-year intravesical recurrence-free survival rate was 83.1%, 82.4%, and 69.2%, for groups 1, 2, and 3, respectively (P=.004). Cancer-specific survival and overall survival were comparable (P=.560 and P=.803, respectively). Diagnostic ureterorenoscopy+biopsy (hazard ratio: 6.88, 95% CI: 2.41-19.65, P < .001) was the only independent predictor of intravesical recurrence in patients with upper tract urothelial cancer located in the kidney, according to tumor location. Conclusion: Diagnostic ureterorenoscopy+biopsy before radical nephroureterectomy significantly increased the rates of intravesical recurrence in tumors located in kidney. This result suggests tumor spillage with this type of biopsy, so further studies with different biopsy options or without biopsy can be designed. Cite this article as: Culpan M, Cakici MC, Keser F, et al. Biopsy with ureterorenoscopy before radical nephroureterectomy is associated with increased intravesical recurrence in urothelial cancer located in the kidney. Turk J Urol. 2022;48(6):431-439.


  • Open Access

    Urethral monopolar cauterization: alternative infravesical obstruction model in male rats

    by Serkan Akan, Hasan Hüseyin Tavukçu, Ibrahim Sogut, Ayşe Gökçen Sade, Yunus Emre Kızılkan, Caner Ediz, Ömer Yilmaz, Haluk Kulaksızoğlu

    OBJECTIVE: We aimed to determine which method gives the most consistent results between urethral monopolar cauterization and standard urethral partial ligation methods for the urethral obstruction model.METHODS: Thirty male rats were randomly divided into control, partial ligation, and monopolar cauterization groups. Six weeks after experimental procedures, the experimental groups were evaluated cystometrically, biochemically, and histologically.RESULTS: According to the cystometric results, bladder capacity, baseline bladder pressure, and compliance data of the monopolar cauterization group were higher than those of the partial ligation and monopolar cauterization groups (p<0.05 and p<0.01, respectively). As a biochemical evaluation, malondialdehyde levels in bladder tissues of group control were higher than partial ligation and monopolar cauterization groups (p<0.05 and p<0.01, respectively). The collagen type I level of the control group was higher than the partial ligation and monopolar cauterization groups (p<0.01 and p<0.05, respectively). Collagen type III levels of the monopolar cauterization group were higher than those of the control group (p<0.01), but the Collagen type I/Collagen type III and transforming growth factor-beta levels of the monopolar cauterization group were significantly lower than those of the control group (p<0.001). As a histological evaluation (hematoxylin and eosin), fibrosis in the lamina propria was more prominent in the monopolar cauterization group than in the control group (p<0.05). In addition, the muscular thickness was higher in the monopolar cauterization group compared with control and partial ligation groups (p<0.001 and p<0.01, respectively).CONCLUSION: The needle-tipped monopolar cauterization of the posterior urethra may be the method of choice for creating a chronic infravesical obstruction model of infravesical obstruction in male rats.


  • A Novel Survey of the Treatment Trends and Technical Details for Extracorporeal Shockwave Lithotripsy From Experienced European Endourologists

    by Serkan Yenigürbüz, Caner Ediz, Cumhur Yeşildal, Mehmet Pehlivanoğlu, Yunus Emre Kızılkan, Hasan Hüseyin Tavukçu, Ömer Yılmaz


  • Correlation of the Grade Group of Prostate Cancer according to the International Society of Urological Pathology (Isup) 2014 Classification between Prostate Biopsy and Radical Prostatectomy Specimens

    by Serkan Akan, Caner Ediz, M. Cihan Temel, Ferhat Ates, Omer Yilmaz

    Abtract We aimed to assess the correlation between ISUP 2014 grades of needle biopsy (NB) and radical prostatectomy (RP) specimens and the parameters effecting this correlation. A total of 353 patients, who underwent a radical prostatectomy with diagnose of prostate cancer, were included in the study. Especially, the maximum percentage of core involved by cancer (MPCI) of upgraded group was significantly higher than those of correlated group and downgraded group. MPCI might be used as a preoperative value to determine risk classification and to help counsel patients with regard to treatment decision and prognosis of disease.


  • Open Access

    COVID-19 infection threat in patients with high-risk non-muscle invasive bladder cancer receiving intravesical BCG therapy

    by Serkan Akan, Caner Ediz, Yunus Emre Kızılkan, Adem Alcin, Hasan Huseyin Tavukcu, Omer Yilmaz

    Aim We evaluated the COVID-19 infection threat in patients receiving intravesical BCG therapy which has immunotherapeutic effects and is of vital importance in most of the individuals with high-risk non-muscle-invasive bladder cancer (NMIBC) and investigated the need for postponement of this therapy. Methods A total of 71 patients, who were diagnosed with high-risk NMIBC and on intravesical BCG treatment regularly (induction or maintenance), were enrolled in the study. The patients were classified into two groups depending on whether they were diagnosed with COVID-19 during the pandemic period or not. Results Of 71 patients, 26 underwent a COVID-19 polymerase chain reaction test with clinical suspicion during the pandemic period. Of these 26 patients, 4 were diagnosed with COVID-19. Age of the patients, working status (working/retired), compliance with containment measures against the pandemic, number of BCG courses, adverse effects after BCG therapy and systemic immune-inflammation index, which is an inflammation-related parameter, were not different between groups (P > .05). Neutrophil/lymphocyte ratio was significantly higher in the COVID-19 positive group (P < .05). COVID-19 positivity was higher in age groups 50-64 (6.6%) and 65-80 (5.8%) years than that in similar age groups of the normal population. Conclusion Every effort should be made to administer intravesical BCG treatment in high-risk NMIBC patients even during the pandemic period. However, increased risk of COVID-19 transmission should be kept in mind and protective measures against COVID-19 for healthcare providers and patients before the procedure should be taken optimally. The procedure should be postponed in patients with lymphopenia in recent complete blood count.


  • Can the systemic immune inflammation index be a predictor of BCG response in patients with high‐risk non‐muscle invasive bladder cancer?

    by Serkan Akan, Caner Ediz, Aytac Sahin, Hasan Huseyin Tavukcu, Ahmet Urkmez, Alper Horasan, Omer Yilmaz, Ayhan Verit

    Aim We aimed to investigate the predictor role of the systemic immune‐inflammation index (SII) on Bacille Calmette Guerin (BCG) response in patients with high‐risk non‐muscle invasive bladder cancer (NMIBC). Methods A total of 96 patients with high‐risk NMIBC, who received intravesical BCG, were enrolled in the study. BCG responsive group (group 1) and BCG failure group (group 2) were compared in terms of demographic and pathological data, peripheral lymphocyte, neutrophil, and platelet counts, neutrophile lymphocyte ratio (NLR), platelet lymphocyte ratio (PLR), SII, recurrence free survival (RFS) and progression free survival (PFS). The prognostic ability of the SII for progression was analyzed with multivariate backward stepwise regression models. Results The mean follow‐up time 34.635±14.7 months. Group 2 had significantly higher SII, peripheral lymphocyte, neutrophil, and platelet counts than group 1. A ROC curve was plotted for the SII to predict the BCG failure and the cut‐off point was calculated as 672.75. Effect of the SII to the model was statistically significant (p=0.003) and a higher SII increased the progression one‐fold. A tumor greater than 30 mm in size and a high SII together increased the progression 3.6 folds. Conclusions The SII might be a successful, non‐invasive and low‐cost parameter for prediction of BCG failure in patients with high‐risk NMIBC. The cut‐off value for SII is 672.75 and above this level BCG failure and progression to MIBC might be anticipated. However, these results should be validated in prospective randomized controlled studies with large patient groups.


  • Comparison of Hounsfield Unit and İntraoperative “GATA Scale” Score to Determine Requirement of DJ Stent Insertion in Ureteral Stone Treatment

    by Caner Ediz, Serkan Akan, Suna Ediz Şahin, Cihan Muhammed Temel, Yunus Emre Kızılkan, Hasan Hüseyin Tavukçu, Ömer Yılmaz